Back to Search
BRIAN WOLPIN, M.D.
M.D.
Medical Oncology Physician
NPI: 1922066893IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
219982(MA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 2001
Research & Publications (17)
ABO blood group and the risk of pancreatic cancer.
PMID 19276450·J Natl Cancer Inst·2009
4-observational
Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
PMID 19064975·J Clin Oncol·2009
8-other
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.
PMID 19047305·J Clin Oncol·2009
3-trial
Prediagnostic plasma folate and the risk of death in patients with colorectal cancer.
PMID 18591557·J Clin Oncol·2008
8-other
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
PMID 17533398·Br J Cancer·2007
8-other
Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancer.
PMID 17026790·Clin Colorectal Cancer·2006
3-trial
Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
PMID 17699799·Cancer Res·2007
8-other
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.
PMID 19648918·Nat Genet·2009
8-other
Defining determinants of pancreatic cancer risk: are we making progress?
PMID 19561317·J Natl Cancer Inst·2009
8-other
A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
PMID 19513025·Am J Gastroenterol·2009
8-other
A cohort study of p27 localization in colon cancer, body mass index, and patient survival.
PMID 19505918·Cancer Epidemiol Biomarkers Prev·2009
8-other
Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
PMID 19073970·Clin Cancer Res·2008
2-rct
Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.
PMID 17905943·Cancer Epidemiol Biomarkers Prev·2007
8-other
Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts.
PMID 17545639·Cancer Res·2007
8-other
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.
PMID 17372756·Virchows Arch·2007
8-other
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.
PMID 15178581·Blood·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 BROOKINE AVE, D1220, DANA FARBER CANCER INSTITUTE
BOSTON, MA 02215 - Phone
- (617) 632-6942
Quick Facts
- NPI
- 1922066893
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 17
Are you this provider?
Claim Your Profile